BioPharm America EBD Group Massachusetts Biotechnology Council BioPharm America
Share:
Email this page Share this on LinkedIn Share this on Twitter

Panelists and Advisors

Philip Astley-Sparke Philip Astley-Sparke
President US,
uniQure
Peter Barrett Peter Barrett
Partner
Atlas Venture
Kees Been Kees Been
President and CEO
Lysosomal Therapeutics Inc.
Rick  Berenson Rick Berenson
CEO, Thermalin Diabetes; Executive Committee Member,
Mass Medical Angels
Karen  Bernstein Karen Bernstein
Co-Founder, Chairman and Editor-in-Chief
BioCentury
David Berry David Berry
Partner
Flagship Ventures
Jeffrey M.  Bockman Jeffrey M. Bockman
VP
Defined Health
Bruce Booth Bruce Booth
Partner
Atlas Venture
Richard Brudnick Richard Brudnick
VP, Co-Head BD/M&A
Biogen Idec
David Collier David Collier
CEO
Velocity Pharmaceutical Development
Stuart Collinson Stuart Collinson
CEO
Tioga Pharmaceuticals
Bernard Davitian Bernard Davitian
VP and Managing Director,
Sanofi-Genzyme BioVentures
Pamela Demain Pamela Demain
Executive Director
Corporate Licensing
Merck & Co. Inc.
Steve Dickman Steve Dickman
CEO
CBT Advisors
Michael Elliott Michael Elliott
VP, Immunology Scientific Innovation
Johnson & Johnson
Meredith Fisher Meredith Fisher
Director and Partner Investments
Private Investment Office
Dennis  Ford Dennis Ford
Founder and CEO
Life Science Nation
Todd Foley Todd Foley
Managing Director
MPM Capital
Arthur Franken Arthur Franken
Partner
Gilde Healthcare
Johannes Fruehauf Johannes Fruehauf
Founder and President
LabCentral
Brian  Gallagher, Jr. Brian Gallagher, Jr.
Partner
SR One
Anand Gautam Anand Gautam
Director, Biopharm Innovation Sourcing
Novo Nordisk
Jim Geraghty Jim Geraghty
Entrepreneur-in-Residence,
Third Rock Ventures
Michael Gilman Michael Gilman
CEO
Padlock Therapeutics
Alexandra Glucksmann Alexandra Glucksmann
Chief Operating Officer
Editas Medicine
Jeff Goater Jeff Goater
VP, Business Development
Voyager Therapeutics
Philip  Gotwals Philip Gotwals
Executive Director Oncology Research Collaborations
Novartis Institutes for BioMedical Research
Robert Gould Robert Gould
CEO
Epizyme
Daniel Grau Daniel Grau
President
Heptares Therapeutics
David Grayzel David Grayzel
Partner
Atlas Venture
Barry   Greene Barry Greene
President and Chief Operating Officer
Alnylam Pharmaceuticals
Christopher D.T.  Guiffre Christopher D.T. Guiffre
Senior VP and Chief Business Officer
Cerulean Pharma
Eric Halioua Eric Halioua
Co-Founder and CEO
Promethera Biosciences
John Hallinan John Hallinan
Chief Business Officer
MassBio
Karin Hehenberger Karin Hehenberger
CEO and Founder
Lyfebulb
Carl  Jessop Carl Jessop
Due Diligence Director
AstraZeneca
Jeff Jonas Jeff Jonas
CEO
Sage Therapeutics
Frederick Jones
Director
Broadview Ventures Inc.
Roger Kitterman Roger Kitterman
Managing Partner
Partners HealthCare Innovation Fund
Adam M. Koppel Adam M. Koppel
Senior VP and Chief Strategy Officer
Biogen Idec
Nilesh Kumar Nilesh Kumar
Director
MS Ventures
Tomas Landh Tomas Landh
Director, Strategy and Innovation Sourcing, Diabetes Research Unit
Novo Nordisk
Jay Lichter
Managing Director
Avalon Ventures
Philippe Lopes-Fernandes Philippe Lopes-Fernandes
Senior VP and Head,
Global Licensing and Business Development
EMD Serono
Douglas MacDougall Douglas MacDougall
President
MacDougall Biomedical Communications
Ed Mathers Ed Mathers
Partner, Washington DC
NEA
Art   McGivern Art McGivern
Partner
Goodwin Procter
Donnie McGrath Donnie McGrath
Vice President, Search and Evaluation, Business Development
Bristol-Myers Squibb
Debra Miller Debra Miller
Founder and CEO
CureDuchenne
Robert Millman Robert Millman
Managing Director, MPM
Co-Founder and President
CoStim Pharmaceuticals
Martina Molsbergen Martina Molsbergen
CEO
C14 Consulting Group
Katy Moore Katy Moore
Senior Director, Scientific Licensing Worldwide Business Development
GlaxoSmithKline
Pieter Muntendam
President and CEO
scPharmaceuticals
Gary Nabel Gary Nabel
CSO
Sanofi
Imran Nasrullah Imran Nasrullah
Head, Strategic Alliances
T1D Exchange
Sridaran Natesan Sridaran Natesan
VP, Stategic Initiatives and Science Relations (North America)
Sanofi
Michele M. Oshman Michele M. Oshman
Director, Federal Alliance Development, Corporate Affairs
Eli Lilly and Company
Dan Paterson Dan Paterson
Chief Business Officer
Verastem
Christoph Pittius Christoph Pittius
VP, Head of Transactions, Business Development
AstraZeneca
Doug Plessinger
VP, Clinical and Medical Affairs
Argos Therapeutics
Richard Pops Richard Pops
Chairman and CEO
Alkermes plc
Michal Preminger Michal Preminger
Executive Director
Office of Technology Development
Harvard University
Dennis J. Purcell Dennis J. Purcell
Founder and Senior Advisor
Aisling Capital
Jeffrey L. Quillen Jeffrey L. Quillen
Partner
Foley Hoag LLP
Liam Ratcliffe Liam Ratcliffe
Managing Director
New Leaf Venture Partners
Debanjan Ray Debanjan Ray
VP, Business Development and Alliance Management
CytomX
Kareem S.  Reda Kareem S. Reda
Director
Business Development
Celgene
Brock Reeve Brock Reeve
Executive Director
Harvard Stem Cell Institute
Isabelle Rivière Isabelle Rivière
Director, Cell Therapy and Cell Engineering Facility
Memorial Sloan Kettering Cancer Center
Greg Robinson Greg Robinson
Senior Director
Scientific Licensing Assessment
Shire
Brian Rosen Brian Rosen
Chief Policy, Advocacy and Patient Access Officer
The Leukemia & Lymphoma Society
Morrie Ruffin Morrie Ruffin
Managing Partner
Adjuvant Partners
Mustafa Sahin Mustafa Sahin
Director, Translational Neuroscience Center
Boston Children's Hospital
David Sandak David Sandak
VP, Strategy and Research
Accelerate Brain Cancer Cure
Arlene H. Sharpe Arlene H. Sharpe
Co-Founder, CoStim Pharmaceuticals; George Fabyan Professor of Comparative Pathology,
Harvard Medical School
John  Sorvillo John Sorvillo
Director, Licensing, Business Development
Amgen
Kumar Srinivasan Kumar Srinivasan
VP, Scientific Partnering and Alliances
AstraZeneca
Kevin Starr Kevin Starr
Partner
Third Rock Ventures
Dave Taylor Dave Taylor
Founder and Managing Director
Mankind Venture Group (MvG)
Benjamin Thorner Benjamin Thorner
Associate VP, Head of Business Development and Licensing, Boston Innovation Hub
Merck
Rafaèle  Tordjman Rafaèle Tordjman
Managing Partner
Sofinnova Partners
Robert Urban Robert Urban
Head
Johnson & Johnson Boston Innovation LLC
David Verrill David Verrill
Founder and Managing Director
Hub Angels Investment Group LLC
Robert Weisskoff Robert Weisskoff
Partner
Fidelity Biosciences
James B.  Weissman James B. Weissman
Chief Business Officer
Dicerna Pharmaceuticals
Robert Willenbucher Robert Willenbucher
Head Cell Therapy
Janssen R&D LLC
David Yeary David Yeary
VP, Life Sciences
Merrill DataSite
Stephen Yoder
Global Lead, CV/Metabolic, Search and Evaluation
Bristol-Myers Squibb
Leigh Zawel Leigh Zawel
Site Head, Boston Center for Therapeutic Innovation (CTI)
Pfizer BioTherapeutics R&D
Daphne Zohar Daphne Zohar
Founder, Managing Partner
PureTech Ventures
Arrow Up


© 2009–2014 EBD Group, Inc.
BioPharm America EBD Group Massachusetts Biotechnology Council BioPharm America